• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ?; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ?; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911320300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atherosclerosis (1728); Chest Pain (1776); Reocclusion (1985)
Event Date 11/27/2013
Event Type  Injury  
Event Description
Same case as mdr id: 2134265-2013-09395 and 2134265-2013-09407.(b)(4) clinical study.It was reported that cardiac chest pain and restenosis occurred.On (b)(6) 2013, identified the subject's qualifying condition was stable angina and the subject was referred for cardiac catheterization.The target lesion 1 was located in the proximal lad (left anterior descending) extending into the mid lad with 99 % stenosis, a length of 17.0 mm, and a reference vessel diameter of 3.0 mm.The target lesion 1 was treated with pre-dilatation, placement of 3.00 x 20 mm and 3.00 x 20 mm study stents, with 0% residual stenosis.The target lesion 2 was located in the 1st diagonal with 99% stenosis, a length of 23 mm, and a reference vessel diameter of 2.50 mm.The target lesion 2 was treated with pre-dilatation, placement of a 2.50 x 24 mm study stent, with 0% residual stenosis.The subject was discharged on the same day on aspirin and clopidogrel.On (b)(6) 2013, the subject was hospitalized and was treated with medication.1 day after, the site reported an event of cardiac chest pain and the subject underwent angiography.6 days after, the subject underwent cabg to the proximal lad and also to 1st diagonal.The subject was recovering and the event was resolving at the time of this report.
 
Manufacturer Narrative
Age at time of event: 18 years or older.(b)(6).Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Manufacturer Narrative
Event date corrected from (b)(6) 2013.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2013-09395 and 2134265-2013-09407.(b)(4).It was reported that cardiac chest pain and restenosis occurred.On (b)(6) 2013, identified the subject's qualifying condition was stable angina and the subject was referred for cardiac catheterization.The target lesion 1 was located in the proximal lad (left anterior descending) extending into the mid lad with 99 % stenosis, a length of 17.0 mm, and a reference vessel diameter of 3.0 mm.The target lesion 1 was treated with pre-dilatation, placement of 3.00 x 20 mm and 3.00 x 20 mm study stents, with 0% residual stenosis.The target lesion 2 was located in the 1st diagonal with 99% stenosis, a length of 23 mm, and a reference vessel diameter of 2.50 mm.The target lesion 2 was treated with pre-dilatation, placement of a 2.50 x 24 mm study stent, with 0% residual stenosis.The subject was discharged on the same day on aspirin and clopidogrel.On (b)(6) 2013, the subject was hospitalized and was treated with medication.One day after, the site reported an event of cardiac chest pain and the subject underwent angiography.Six days after, the subject underwent cabg to the proximal lad and also to 1st diagonal.The subject was recovering and the event was resolving at the time of this report.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Same case as mdr id: 2134265-2014-06335, 2134265-2013-09395 and 2134265-2013-09407.It was further reported that an event of "coronary atherosclerotic heart disease" instead of previously reported event of cardiac chest pain.A 3.5x24mm promus element stent was also implanted in the proximal lad lesion in (b)(6) 2013.14 days following cabg procedure the patient was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ?
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key3557257
MDR Text Key4212195
Report Number2134265-2013-09394
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCN
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/09/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/14/2014
Device Model NumberH7493911320300
Device Catalogue Number39113-2030
Device Lot Number15615538
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/11/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/05/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
-
-